Physician
Endocrinology
Dr. Matthew D. Ringel, MD
|
|
Give Review
Matthew Ringel works in the field of Endocrinology. Matthew Ringel is a published doctor and has 101 publications published. The lastest was: 'Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid in peripheral blood.' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Thyroid carcinoma, version 2.2014.
- Development of a Calcium-sensing receptor molecular imaging agent.
- Localization of CaSR Antagonists in CaSR-expressing Medullary Thyroid Cancer.
- Development of p21 Activated Kinase-Targeted Multikinase Inhibitors That Inhibit Thyroid Cancer Cell Migration.
- SRGAP1 Is a Candidate Gene for Papillary Thyroid Carcinoma Susceptibility.
- MicroRNA Signature in Thyroid Fine Needle Aspiration Cytology Applied to "Atypia of Undetermined Significance" Cases.
- Sorafenib and Mek Inhibition are Synergistic in Medullary Thyroid Carcinoma in Vitro.
- Germline SDHx variants modify breast and Thyroid cancer risks in Cowden and Cowden-like syndrome via FAD/NAD-dependant destabilization of p53.
- Telomere length and telomerase reverse transcriptase gene copy number in patients with papillary Thyroid carcinoma.
- Epigenetic deregulation of TCF21 inhibits metastasis suppressor KISS1 in metastatic melanoma.
- High-Sensitivity TFA-free LC-MS for Profiling Histones.
- Multi-institutional phase II study of selumetinib in patients with metastatic biliary Cancers.
- Metastatic Dormancy and Progression in Thyroid Cancer: Targeting Cells in the Metastatic Frontier.
- Frequency of Germline PTEN Mutations in Differentiated Thyroid Cancer.
- Linking oncogenes to invasion in Thyroid cancer.
- The relationship between body mass index and Thyroid cancer pathology features and outcomes: a clinicopathological cohort study.
- Reply to A. Machens et al.
- Phase II clinical trial of sorafenib in metastatic medullary Thyroid cancer.
- Long-term efficacy of lymph node reoperation for persistent papillary Thyroid cancer.
- Frontiers in Thyroid cancer: December 2009.
- Phase II trial of sorafenib in metastatic Thyroid cancer.
- Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to Thyroid cancer.
- Lack of therapeutic effect of the histone deacetylase inhibitor vorinostat in patients with metastatic radioiodine-refractory Thyroid carcinoma.
- Combined use of perioperative TSH-stimulated (18)F-FDG PET/CT imaging and gamma probe radioguided surgery to localize and verify resection of iodine scan-negative recu...
- "Thyroid cancer" cell line misidentification: a time for proactive change.
- Dysregulation of the phosphatidylinositol 3-kinase pathway in Thyroid neoplasia.
- 2-amino-N-{4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-phenyl} acetamide (OSU-03012), a celecoxib derivative, directly targets p21-activated kinase.
- A novel PTEN mutation in Cowden Syndrome is associated with a mixed degenerative-erosive arthritic process: potential molecular pathogenic mechanisms.
- AKT in Thyroid tumorigenesis and progression.
- Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary Thyroid carcinoma invasion.
- Phase II study of celecoxib in metastatic differentiated Thyroid carcinoma.
- BRAF mutation predicts a poorer clinical prognosis for papillary Thyroid cancer.
- A mouse model of albright hereditary osteodystrophy generated by targeted disruption of exon 1 of the Gnas gene.
- Dystrophin glycoprotein complex Dysfunction: a regulatory link between muscular dystrophy and cancer cachexia.
- AKT activation promotes metastasis in a mouse model of follicular Thyroid carcinoma.
- KiSS-1/G protein-coupled receptor 54 metastasis suppressor pathway increases myocyte-enriched calcineurin interacting protein 1 expression and chronically inhibits cal...
- Akt1 contains a functional leucine-rich nuclear export sequence.
- Papillary and follicular variant of papillary carcinoma of the Thyroid: Initial presentation and response to therapy.
- Thyrocytes express a functional toll-like receptor 3: overexpression can be induced by viral infection and reversed by phenylmethimazole and is associated with Hashimo...
- Genetic classification of benign and malignant Thyroid follicular neoplasia based on a three-gene combination.
- Subclinical Thyroid dysfunction--can there be a consensus about the consensus?
- Chronic expression of RET/PTC 3 enhances basal and insulin-stimulated PI3 kinase/AKT signaling and increases IRS-2 expression in FRTL-5 Thyroid cells.
- 17-Allylamino-17-demethoxygeldanamycin activity against Thyroid cancer cell lines correlates with heat shock protein 90 levels.
- Diagnostic molecular markers in Thyroid cancer.
- Molecular detection of Thyroid cancer: differentiating "signal" and "noise" in clinical assays.
- Akt controls vascular smooth muscle cell proliferation in vitro and in vivo by delaying G1/S exit.
- Epidermal growth factor inhibition of c-Myc-mediated apoptosis through Akt and Erk involves Bcl-xL upregulation in mammary epithelial cells.
- Clinical review 158: Beyond radioiodine: a review of potential new therapeutic approaches for Thyroid cancer.
- Current therapy for childhood Thyroid cancer: optimal surgery and the legacy of king pyrrhus.
- Vascular endothelial growth factor monoclonal antibody inhibits growth of anaplastic Thyroid cancer xenografts in nude mice.
- Determination of galectin-3 messenger ribonucleic Acid overexpression in papillary Thyroid cancer by quantitative reverse transcription-polymerase chain reaction.
- Paternal imprinting of Galpha(s) in the human Thyroid as the basis of TSH resistance in pseudohypoparaThyroidism type 1a.
- Evaluation of adult papillary Thyroid carcinomas by comparative genomic hybridization and microsatellite instability analysis.
- Metastin receptor is overexpressed in papillary Thyroid cancer and activates MAP kinase in Thyroid cancer cells.
- Group I p21-activated kinases regulate Thyroid cancer cell migration and are overexpressed and activated in Thyroid cancer invasion.
- Regulator of calcineurin 1 modulates Cancer cell migration in vitro.
- Regulation of actin function by protein kinase A-mediated phosphorylation of Limk1.
- Medullary Thyroid cancer: management guidelines of the American Thyroid Association.
- Molecular markers of aggressiveness of Thyroid cancer.
- The PI3K-Akt-mTOR pathway in initiation and progression of Thyroid tumors.
- Do tumor characteristics predict risk of malignancy in Thyroid nodules with indeterminate cytology?
- Rosiglitazone sensitizes MDA-MB-231 breast Cancer cells to anti-tumour effects of tumour necrosis factor-alpha, CH11 and CYC202.
- Can ultrasound and clinical features be used to predict Thyroid cancer in solitary nodules and multinodular goiter?
- Akt: a potential target for Thyroid cancer therapy.
- Thyroid follicular adenomas may display features of follicular carcinoma and follicular variant of papillary carcinoma.
- Systemic administration of vascular endothelial growth factor monoclonal antibody reduces the growth of papillary Thyroid carcinoma in a nude mouse model.
- Integrating fine-needle aspiration into a daily practice involving Thyroid disorders: the Washington Hospital Center approach.
- Measurement of thyroglobulin mRNA in peripheral blood as an adjunctive test for monitoring Thyroid cancer.
- Molecular diagnosis of residual and recurrent Thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid in peripheral blood.
- Trading one "dangerous dogma" for another? Thyroid hormone treatment of the "euThyroid sick syndrome".
- Quantitative reverse transcription-PCR measurement of thyroglobulin mRNA in peripheral blood of healthy subjects.
- Quantitative reverse transcription-polymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with Thyroid carcinoma.
- Tall cell variant: an aggressive form of papillary Thyroid carcinoma.
- Prognostic importance of vascular invasion in papillary Thyroid carcinoma.
- Diagnostic accuracy of 131I scanning with recombinant human thyrotropin versus Thyroid hormone withdrawal in a patient with metastatic Thyroid carcinoma and hypopituit...
- Clinical implications of genetic defects in G proteins. The molecular basis of McCune-Albright Syndrome and Albright hereditary osteodystrophy.
- Unusual types of Thyroid neoplasms.
- Augmented hepatic and skeletal thyromimetic effects of tiratricol in comparison with levothyroxine.
- Hodgkin's Disease treated with neck radiation is associated with increased antibody-dependent cellular cytotoxicity against human extraocular muscle cells.
- Resistance to TSH in patients with normal TSH receptors--where do we turn when "Sutton's law" proves false?
- Determination of transgene copy number and expression level using denaturing gradient gel electrophoresis.
- Absence of activating mutations of the genes encoding the alpha-subunits of G11 and Gq in Thyroid neoplasia.
- HyperThyroid heart disease.
- The role of radioactive iodine in salivary Gland dysfunction.
- Cytotoxic activity of 2',2'-difluorodeoxycytidine (gemcitabine) in poorly differentiated Thyroid carcinoma cells.
- Ultrasound-guided fine-needle aspiration and Thyroid disease.
- Management of hypoThyroidism and hyperThyroidism in the intensive care unit.
- Thyroglobulin messenger ribonucleic acid levels in the peripheral blood of children with benign and malignant Thyroid disease.
- Expression of the sodium iodide symporter and thyroglobulin genes are reduced in papillary Thyroid cancer.
- Regulation of FRTL-5 Thyroid cell growth by phosphatidylinositol (OH) 3 kinase-dependent Akt-mediated signaling.
- Overexpression and overactivation of Akt in Thyroid carcinoma.
- Sudden enlargement of local recurrent Thyroid tumor after recombinant human TSH administration.
- Molecular diagnostic tests in the diagnosis and management of Thyroid carcinoma.
- Targeting BRAF in Thyroid cancer.
- BRAF T1796A transversion mutation in various Thyroid neoplasms.
- Controversies in the follow-up and management of well-differentiated Thyroid cancer.
- ret/PTC1 and ret/PTC3 in Thyroid tumors from Chernobyl liquidators: comparison with sporadic tumors from Ukrainian and French patients.
- Akt activation and localisation correlate with tumour invasion and oncogene expression in Thyroid cancer.
- Beyond peroxisome proliferator-activated receptor gamma signaling: the multi-facets of the antitumor effect of thiazolidinediones.
- Akt1 deficiency delays tumor progression, vascular invasion, and distant metastasis in a murine model of Thyroid cancer.
Schools
Pennsylvania State University College Of Medicine
Georgetown University
Johns Hopkins University School Med
Conditions Treated
- Abnormal Thyroid
- Adrenal Incidentaloma
- Calcium Metabolism Disorders
- Cushing's Syndrome
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
Drug Facts
| NPI NUMBER | 1306853106 | |
| NPPES Provider LastName | RINGEL | |
| NPPES Provider FirstName | MATTHEW | |
| NPPES Provider ZIPCode | 432101240 | |
| NPPES Provider State | OH | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 289.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1306853106 |
| Last Name Of The Provider | RINGEL |
| First Name Of The Provider | MATTHEW |
| View All |
Similar Doctors
|
Dr. Kathleen M. Dungan, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. William B. Malarkey, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Rundsarah M. Tahboub, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Kwame Osei, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Susannah M. Becker, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shumei Meng, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elena A. Christofides, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Rajaram J. Karne, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Michael S. Berk, OD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Raheela A. Khawaja, MD
This Doctor is OpenDoctor Recommended.
|